142 related articles for article (PubMed ID: 38653110)
1. The multifaceted mechanisms of Dihydrotanshinone I in the treatment of tumors.
Yue J; Hao D; Wang Y; Guo J; Liu S; Meng L; Liu J
Biomed Pharmacother; 2024 Jun; 175():116635. PubMed ID: 38653110
[TBL] [Abstract][Full Text] [Related]
2. Dihydrotanshinone-I modulates Epithelial Mesenchymal Transition (EMT) Thereby Impairing Migration and Clonogenicity of Triple Negative Breast Cancer Cells.
Kashyap A; Umar SM; Dev J R A; Prasad CP
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2177-2184. PubMed ID: 34319041
[TBL] [Abstract][Full Text] [Related]
3. 15,16-Dihydrotanshinone I from the Functional Food Salvia miltiorrhiza Exhibits Anticancer Activity in Human HL-60 Leukemia Cells: in Vitro and in Vivo Studies.
Liu JJ; Wu HH; Chen TH; Leung W; Liang YC
Int J Mol Sci; 2015 Aug; 16(8):19387-400. PubMed ID: 26287183
[TBL] [Abstract][Full Text] [Related]
4. Dihydrotanshinone I inhibits ovarian cancer cell proliferation and migration by transcriptional repression of PIK3CA gene.
Wang X; Xu X; Jiang G; Zhang C; Liu L; Kang J; Wang J; Owusu L; Zhou L; Zhang L; Li W
J Cell Mol Med; 2020 Oct; 24(19):11177-11187. PubMed ID: 32860347
[TBL] [Abstract][Full Text] [Related]
5. Salvia miltiorrhiza inhibited lung cancer through aerobic glycolysis suppression.
Bai J; Qin Q; Li S; Cui X; Zhong Y; Yang L; An L; Deng D; Zhao J; Zhang R; Bai S
J Ethnopharmacol; 2024 Sep; 331():118281. PubMed ID: 38701934
[TBL] [Abstract][Full Text] [Related]
6. Identification of dihydrotanshinone I as an ERp57 inhibitor with anti-breast cancer properties via the UPR pathway.
Shi W; Han H; Zou J; Zhang Y; Li H; Zhou H; Cui G
Biochem Pharmacol; 2021 Aug; 190():114637. PubMed ID: 34062127
[TBL] [Abstract][Full Text] [Related]
7. Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza.
Hu T; To KK; Wang L; Zhang L; Lu L; Shen J; Chan RL; Li M; Yeung JH; Cho CH
Phytomedicine; 2014 Sep; 21(11):1264-72. PubMed ID: 25172788
[TBL] [Abstract][Full Text] [Related]
8. Dihydrotanshinone I inhibits gallbladder cancer growth by targeting the Keap1-Nrf2 signaling pathway and Nrf2 phosphorylation.
Li Z; Mo RL; Gong JF; Han L; Wang WF; Huang DK; Xu JG; Sun YJ; Chen S; Han GC; Sun DQ
Phytomedicine; 2024 Jul; 129():155661. PubMed ID: 38677269
[TBL] [Abstract][Full Text] [Related]
9. Molecular evidence of cryptotanshinone for treatment and prevention of human cancer.
Chen W; Lu Y; Chen G; Huang S
Anticancer Agents Med Chem; 2013 Sep; 13(7):979-87. PubMed ID: 23272908
[TBL] [Abstract][Full Text] [Related]
10. Dihydrotanshinone I Inhibits Pancreatic Cancer Progression
Huang W; Dai Y; Xu L; Mao Y; Huang Z; Ji X
Curr Cancer Drug Targets; 2023; 23(9):731-741. PubMed ID: 37018533
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological activities of dihydrotanshinone I, a natural product from Salvia miltiorrhiza Bunge.
Chen X; Yu J; Zhong B; Lu J; Lu JJ; Li S; Lu Y
Pharmacol Res; 2019 Jul; 145():104254. PubMed ID: 31054311
[TBL] [Abstract][Full Text] [Related]
12. 15,16-dihydrotanshinone I inhibits EOMA cells proliferation by interfering in posttranscriptional processing of hypoxia-inducible factor 1.
Duan P; Huang Y; Chen K; Cheng C; Wu Z; Wu Y
Int J Med Sci; 2021; 18(14):3214-3223. PubMed ID: 34400891
[TBL] [Abstract][Full Text] [Related]
13. Salvia miltiorrhiza extract dihydrotanshinone induces apoptosis and inhibits proliferation of glioma cells.
Cao Y; Huang B; Gao C
Bosn J Basic Med Sci; 2017 Aug; 17(3):235-240. PubMed ID: 28485251
[TBL] [Abstract][Full Text] [Related]
14. Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling.
Zhang Y; Won SH; Jiang C; Lee HJ; Jeong SJ; Lee EO; Zhang J; Ye M; Kim SH; Lü J
Pharm Res; 2012 Jun; 29(6):1595-608. PubMed ID: 22281759
[TBL] [Abstract][Full Text] [Related]
15. Dihydrotanshinone I Enhances Cell Adhesion and Inhibits Cell Migration in Osteosarcoma U-2 OS Cells through CD44 and Chemokine Signaling.
Fan L; Peng C; Zhu X; Liang Y; Xu T; Xu P; Wu S
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744840
[TBL] [Abstract][Full Text] [Related]
16. 15,16-Dihydrotanshinone I-induced apoptosis in human colorectal cancer cells: involvement of ATF3.
Suk FM; Jou WJ; Lin RJ; Lin SY; Tzeng FY; Liang YC
Anticancer Res; 2013 Aug; 33(8):3225-31. PubMed ID: 23898083
[TBL] [Abstract][Full Text] [Related]
17. [Anticancer effect of tanshinone and its mechanisms].
Yuan SL; Wang XJ; Wei YQ
Ai Zheng; 2003 Dec; 22(12):1363-6. PubMed ID: 14693071
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect and molecular mechanism of antioxidant polysaccharides from Salvia miltiorrhiza Bunge in human colorectal carcinoma LoVo cells.
Wang X; Gao A; Jiao Y; Zhao Y; Yang X
Int J Biol Macromol; 2018 Mar; 108():625-634. PubMed ID: 29233711
[TBL] [Abstract][Full Text] [Related]
19. Biotin-Modified Polylactic- co-Glycolic Acid Nanoparticles with Improved Antiproliferative Activity of 15,16-Dihydrotanshinone I in Human Cervical Cancer Cells.
Luo J; Meng X; Su J; Ma H; Wang W; Fang L; Zheng H; Qin Y; Chen T
J Agric Food Chem; 2018 Sep; 66(35):9219-9230. PubMed ID: 30102527
[TBL] [Abstract][Full Text] [Related]
20. New developments in the chemistry and biology of the bioactive constituents of Tanshen.
Wang X; Morris-Natschke SL; Lee KH
Med Res Rev; 2007 Jan; 27(1):133-48. PubMed ID: 16888751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
